Entyvio 300 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FKAY3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,865
Award facts
- Contract value 100% obligated
- $19,865.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $19,865 delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Entyvio 300 mg vials.
PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with ultimate completion on April 9, 2026.
Quick answers
Who was awarded contract SPE2DR26FKAY3?
SPE2DR26FKAY3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 8, 2026.
How much is contract SPE2DR26FKAY3 worth?
The government has obligated $19,865 on SPE2DR26FKAY3.
Is contract SPE2DR26FKAY3 an order under another contract?
Yes. SPE2DR26FKAY3 is a delivery order under SPE2DR25D9365, an indefinite delivery contract.
Was contract SPE2DR26FKAY3 competed?
The extent of competition for SPE2DR26FKAY3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award